SCHEDULE 13G/A: BlackRock Boosts AtriCure Stake to 7.8%
Beneficial Ownership Report
BlackRock, Inc. has reported an increased beneficial ownership of 7.8% in AtriCure Inc.'s common stock, holding 3,862,837 shares as of September 30, 2025.
Summary
- BlackRock, Inc. beneficially owns 3,862,837 shares of AtriCure Inc. Common Stock.
- This ownership represents 7.8% of the total outstanding class of securities.
- BlackRock, Inc. holds sole voting power over 3,782,723 shares.
- BlackRock, Inc. holds sole dispositive power over 3,862,837 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of AtriCure Inc.
- Various BlackRock business units and subsidiaries contribute to this aggregate beneficial ownership, including BlackRock Advisors, LLC and BlackRock Fund Advisors.
Sentiment
Score: 7
Explanation: The filing indicates a significant, passive institutional investment by BlackRock in AtriCure Inc., which is generally viewed as a positive signal of confidence from a major asset manager.
Positives
- Increased institutional ownership by a major asset manager like BlackRock can signal confidence in AtriCure Inc.'s long-term prospects.
- The acquisition of shares is stated to be in the ordinary course of business, indicating a passive investment strategy rather than an attempt to influence control.
Risks
- The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating immediate control-related risks for AtriCure Inc.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding AtriCure Inc.'s operational or financial performance.
Management Comments
- BlackRock, Inc. certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of AtriCure Inc.
Industry Context
BlackRock, as one of the world's largest asset managers, frequently reports significant passive stakes in publicly traded companies across various sectors. AtriCure Inc. operates in the medical device industry, focusing on cardiac and thoracic surgery solutions. BlackRock's investment reflects a general institutional interest in the healthcare and medical technology sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | BlackRock, Inc. executed a new Power of Attorney on January 21, 2025, revoking a previous one from April 30, 2023. This grants specific individuals the authority to execute and file ownership or control-person reporting requirements on behalf of BlackRock and its affiliates. | 2025-01-21 | This is an internal corporate governance update for BlackRock, streamlining its SEC filing processes. It does not directly impact AtriCure Inc.'s corporate governance. |
Stakeholder Impact
- Shareholders: May view BlackRock's increased stake as a positive indicator of institutional confidence in AtriCure Inc.'s value and future performance.
- Management: The passive nature of BlackRock's investment suggests no immediate pressure for strategic or operational changes from this shareholder.
Key Dates
| Date | Description |
|---|---|
| 2025-01-21 | Date of execution of the Power of Attorney by BlackRock, Inc. |
| 2025-09-30 | Date of event which requires the filing of this statement. |
| 2025-10-17 | Date of signature for the Schedule 13G filing. |
Keywords
AtriCure Inc., BlackRock, Institutional Ownership, Common Stock, Beneficial Ownership, Medical Devices, Healthcare, SEC Filing, Schedule 13G
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.